Poster Session 2.B - Molecular Medicine
Raufi, Jamila, MSc
SGKAVL
Pediatric Center, MTA Center of Excellence, Semmelweis University, Budapest, Hungary
+36703228299
raufi.jamila@phd.semmelweis.hu
Antifibrotic Effects of Spirulina maxima Derived Extracellular Vesicles
Jamila Raufi1, Beáta Szebeni1,2, Mária Bernáth1, Péter Bokrossy1, Domonkos Pap1,2, Zoltán Molnár3, Tamás Mészáros4,5,6, Dorina Lenzinger7, Tamás Visnovitz7,8, Marcell Pálmai9, Judith Mihály9, Zoltán Varga9,10,11, Nóra Fekete7, Éva Pállinger7, Apor Veres-Székely1,2, Csenge Szász1, Edit Buzás7,12, Attila J. Szabó1,2, Ádám Vannay1,2
1: Pediatric Center, MTA Center of Excellence, Semmelweis University, Budapest, Hungary
2: HUN-REN-SU Pediatrics and Nephrology Research Group, Budapest, Hungary
3: Department of Plant Sciences, Albert Kázmér Faculty of Agricultural and Food Sciences in Mosonmagyaróvár, Széchenyi István University, Mosonmagyaróvár, Hungary
4: Department of Translational Medicine, Nanomedicine Research and Education Center, Semmelweis University, Budapest, Hungary
5: SeroScience Ltd., Budapest, Hungary
6: Heart and Vascular Center, Faculty of Medicine, Semmelweis University, Budapest, Hungary
7: Institute of Genetics, Cell - and Immunobiology, Semmelweis University, Budapest, Hungary
8: Department of Plant Physiology and Molecular Plant Biology, ELTE Eötvös Loránd University, Budapest, Hungary
9: Biological Nanochemistry Research Group, Institute of Materials and Environmental Chemistry, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary
10: Department of Physical Chemistry and Materials Science, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Budapest, Hungary
11: Department of Biophysics and Radiation Biology - HUN-REN Office for Supported Research Groups, Faculty of Medicine, Semmelweis University, Budapest, Hungary
12: HUN- REN-SU Translational Extracellular Vesicle Research Group, Budapest, Hungary
Poszter
Poster Session 2.B - Molecular Medicine
Hungarian
Molecular Medicine
Antifibrotic Effects of Spirulina maxima Derived Extracellular Vesicles
Abstract
Introduction
Spirulina maxima (Sm) is a nutrient-rich blue-green microalga known for its well-established antioxidant and anti-inflammatory properties. Recent studies suggest that extracellular vesicles (EVs) derived from algae may play a role in mediating these effects, however their specific involvement in fibrosis remains unclear.
Aims
The present study aimed to characterize small EVs produced by Sm (Sm_sEVs) and evaluate their antifibrotic effects in vitro and in vivo.
Methods
Sm_sEVs were isolated from Sm culture medium using tangential flow filtration (TFF) followed by size exclusion chromatography (SEC). Vesicles were characterized by nanoparticle tracking analysis (NTA), transmission electron microscopy, immunogold TEM, surface enhanced IR spectroscopy, and flow cytometry. Cellular uptake of DiI labeled sEVs by human primary peritoneal mesothelial cells (P MCs) and peritoneal fibroblasts (P FBs) was assessed using fluorescence microscopy. Antifibrotic effects were evaluated by immunofluorescence staining, MTT proliferation assays, and Sirius Red collagen accumulation assays. In vivo efficacy was examined in a chlorhexidine digluconate induced mouse model of peritoneal fibrosis.
Results
Sm sEVs were small, spherical vesicles (~150 nm) containing PARK7 and HSP70 proteins. They were efficiently internalized by P MCs and P FBs. Moreover, Sm sEVs inhibited PDGF B–induced proliferation in both cell types, as well as TGF β–induced mesenchymal transition in P MCs and collagen production in P FBs. In vivo, Sm sEV treatment significantly reduced fibrotic changes.
Conclusion
Sm_sEVs exhibit strong antifibrotic activity, highlighting their potential as an algae based therapeutic strategy for fibrotic diseases.
Funding
This research was supported by K-142728 (AJSZ), K-131594 (JM), ADVANCED 150767 (EB), ADVANCED-150077 (ZV), ADVANCED-152698 (JM), ADVANCED- 152112 (TV), TKP2021-EGA-24 (AJSZ), TKP2021-EGA-23 (ÉP), TKP2021-EGA-31 (ZV), STARTING
150629 (ZV), EKÖP-2025-367 (CS); EKÖP-2025-376 (PB); VEKOP-2.3.2-162016-00002 (EB), VEKOP-2.3.3-15-2017-00016 (EB), RRF-2.3.121-2022-00003 (EB), Hungarian Academy of Sciences, János Bolyai Research Scholarship (BS, TV, ZV).
Semmelweis University
Dr. Ádám Vannay
I do not give consent to the publication of my abstract on the website of the congress.
in doctoral studies before complex exam (PhD)
Szabad
elfogadva
poszter
nem rendelkezett róla
9712
18:18
18:21